AIM ImmunoTech (AIM) Cash from Investing Activities (2010 - 2026)
AIM ImmunoTech (AIM) reported Cash from Investing Activities of -$112,000 for Q2 2026, compared with $754,000 a year earlier.
Powered by 
Analysis
AIM ImmunoTech (AIM) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, AIM ImmunoTech's Cash from Investing Activities came in at $52,000, down 99.1% year-over-year; for FY2025, it came in at $1.85 million, down 60.6% from FY2024.
- By year, Cash from Investing Activities came in at $4.71 million in FY2024, -$832,000 in FY2023, $10.99 million in FY2022 and -$631,000 in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Cash from Investing Activities since Q1 2024.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$37,000 (Q1 2026), -$95,000 (Q4 2025) and $296,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | AIM ImmunoTech | 3.08 Mn | -18.22 Mn | 21,000.00 | -112,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -112,000.00 |
| Mar 31, 2026 | -37,000.00 |
| Dec 31, 2025 | -95,000.00 |
| Sep 30, 2025 | 296,000.00 |
| Jun 30, 2025 | 754,000.00 |
| Mar 31, 2025 | 898,000.00 |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | 334,000.00 |
| Jun 30, 2024 | 826,000.00 |
| Mar 31, 2024 | -158,000.00 |
| Dec 31, 2023 | -214,000.00 |
| Sep 30, 2023 | -336,000.00 |
| Jun 30, 2023 | -204,000.00 |
| Mar 31, 2023 | -78,000.00 |
| Dec 31, 2022 | 3.36 Mn |
| Sep 30, 2022 | 250,000.00 |
| Jun 30, 2022 | 7.72 Mn |
| Mar 31, 2022 | -346,000.00 |
| Dec 31, 2021 | 364,000.00 |
| Sep 30, 2021 | -366,000.00 |
API Access
AIM ImmunoTech Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=AIM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "AIM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=AIM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();